Calma Protocol
Data-informed writing on bloodwork, blood pressure, body composition, supplement tracking, and protocol sequencing. Written for people running their own health protocols who want their data to actually mean something.
Latest
-
Can you lower Lp(a)? The drugs in trials, and why none is approved yet
For years the only advice on a high Lp(a) was to drive every other risk factor down, because nothing touched the number itself. Five drugs are about to change that, and the first real test of whether it matters has not reported yet.
-
Can a smartwatch measure blood pressure? What the 2025 guideline says
A wrist reading that appears with no cuff and no ritual is the number everyone wants. It is also the one the 2025 guideline tells you not to rely on, and the reason is measurement, not brand.
-
Nattokinase bleeding risk: aspirin, blood thinners, and surgery
The same fibrinolytic action that makes nattokinase interesting is what puts people in the emergency room. Two case reports, both fatal-adjacent, show the two ways it goes wrong.
-
Does TRT raise blood pressure? What the FDA label change means
The heart risk on testosterone was not erased, it was made specific. The FDA moved it from a boxed warning nobody could act on to a number you can measure at home for the price of a cuff.
-
The rapamycin reversal: why the longevity crowd is backing off
The best-evidenced longevity drug in mice had its confidence knocked in 2024 and 2025. A null human trial, an epigenetic warning sign, and one very public quit.